We're on the Move! Starting from May 28th, 2024, you will find all the details of our Recombumin® portfolio and Albumedix' services at our new online home, sartorius.com
Albumedix Media

Media

What is it that you're looking for?

In our Scientific Library, you'll find scientific papers authored and co-authored by some of Albumedix' leading scientists as well as our collaborators and partners. The News & Events section will bring you up to speed on what we're up to and which conferences you can expect to see us at. Finally, if you're looking to learn a little more about who we are as a business, the Blog is the best place to go. 

Scientific Library News & Events Albumedix Blog

CONTACT

Albumedix Ltd.
Mabel Street
The Meadows
Nottingham
NG2 3ED, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

 

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with ~100 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

 

Privacy | Cookies | Patent Portfolio

ALBUMEDIX, the ALBUMEDIX LOGO, DEDICATED TO BETTER HEALTH and marks such as RECOMBUMIN and VELTIS are trademarks of Albumedix. Albumedix© Copyright 2018

FOLLOW US